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Abstract
The majority of species of the human gut microbiota is not cultivated on artificial nutri‐
ent media, but they are included in the functioning of microbial metabolic conveyor. 
Between the numerous gut bacteria (transmitter) and billions of intracellular mitochon‐
dria (receiver), the function of signaling molecules performs aromatic metabolites. Sepsis 
destroys the coordinated work of the indigenous anaerobic microflora. This leads to the 
imbalance of aromatic microbial metabolites (AMM). We hypothesized and proved diag‐
nostic and pathogenic significance of this. First, deficiency of the end products of micro‐
bial metabolism—lipophilic AMM (PhPA and derivatives‐cinnamic and benzoic acids) 
in sepsis, and second, excessive accumulation in blood of intermediate products named, 
“sepsis‐associated” AMM—both lead to the development of mitochondrial dysfunction. 
Particularly, the total suppressed production of mROS can manifest by “hibernate‐like 
state” of cells and lead to MOF. The participation of aromatic metabolites in the devel‐
opment of septic shock can be explained by the inhibition of tyrosine hydroxylase and 
impaired synthesis of catecholamines. In clinical research, the high levels of “sepsis‐asso‐
ciated” AMM (p‐HPhAA, p‐HPhLA, and PhLA) correlate with the severity according to 
APACHE II, Sepsis‐related Organ Failure Assessments (SOFA) score and mortality. To 
improve the survival of ICU patients, requires more attention to the role of imbalance of 
microbial metabolites in sepsis.
Keywords: sepsis, microbiota, aromatic microbial metabolites, organ dysfunction, 
mitochondrial dysfunction, tyrosine, septic shock
1. Introduction
Currently, improvement of diagnostic and medical technologies in surgery and intensive 
care allows us to provide real treatment of patients, including previously considered incur‐
able. However, the development of infectious complications, syndrome of multiple organ 
failure (MOF), and septic shock significantly worsens the results. Every year the problem of 
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increasing sepsis‐associated mortality becomes more acute in different categories of high‐risk 
patients (e.g., premature infants and elderly, patients with cancer, diabetes mellitus, states 
after injuries, strokes, surgeries, transplants, etc.). Further progress in medicine is impossible 
without a revision of basic ideas about the important role of metabolic disturbances of the 
microbiota in the pathogenesis of sepsis. Nowadays, the question of the role of the microbiota 
comes to the forefront. Numerous research teams conduct in‐depth study using the most con‐
temporary technologies, including metagenomics sequencing, etc. Identifying the microbial 
DNA and RNA, scientists try to decipher hundreds of species of microorganisms living in the 
human gut. It is important to note that the majority of species of the intestinal microbiota of 
man is not cultivated on artificial nutrient media, but is included in the functioning of mul‐
tistage microbial metabolic reactor [1]. More and more data appear on crosstalk between the 
organism and host microbial ecology, including epigenomic and metagenomic programming 
with the involvement of gut microbiota [2]. There are serious reasons to believe that in order 
to decipher mechanisms of sepsis, it is essential to evaluate the functional component of the 
microbial metabolism. Integration of the metabolism of the host and its normal microbiota 
provides the human health sepsis means a profound failure in the general metabolic path‐
ways of man and microbiota, often irreversible that leads to unfavorable outcome.
The absence of a unique approach to an objective assessment of vital threat of damage in 
the main integration points of host‐microbial metabolism makes difficult an early diagnosis, 
prognosis, and targeted treatment of sepsis. In this chapter, we summarize knowledge avail‐
able from the literature and the results of our own experience of research, the pathogenetic 
significance of some microbial metabolites in sepsis—at the organismal, cellular, and subcel‐
lular levels.
2. Microbial metabolism in healthy and in sepsis
The symbiosis of the host and its microbiota exists due to the large number and variety of 
species of bacteria (aerobic, facultative anaerobic, and strict anaerobic bacteria). The micro‐
ecological system is the boundary of the inner sterile environment from the external world 
(all of the mucous membranes and skin), but most richly represented in the gut microbiota.
A large number of different types of microorganisms perform the biochemical functions as 
a multilevel “conveyor”, which involved numerous members of the microbiota. The result 
depends on many factors. The quality and quantity of substrate (food components), the func‐
tion of the stomach, pancreas, liver, gallbladder, and bowel motility, etc. definitely influence 
the metabolism of microbiota. At the same time, the diversity of species with different bio‐
chemical activity provides coordinated work of the microbiota. Therefore, in normal biotrans‐
formation of any of the substrates in the intestinal lumen takes place sequentially and ends 
with the formation of the final metabolites.
It is important to note that many microbial metabolites have biological activity and perform 
important functions in the host organism. They are necessary for the normal functioning 
of organs and systems. For example, fecal short‐chain fatty acids (SCFAs) are important 
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energy substrate for enterocytes. They provide functioning of the local immunological 
barrier, preventing bacterial translocation. SCFAs are sent directly into the cells of the 
intestinal epithelium and “delayed” at the level of the mucosa, therefore, normally they 
are not detected in the blood of healthy people. Other products of microbial metabolism 
permanently enter the internal environment of the organism (blood and lymph); therefore, 
they are called extracellular microbial metabolites or exometabolites.
In the body of a healthy person have well‐functioning mechanisms to maintain the homeosta‐
sis of microbial metabolites at a constant level [3]. If microbial exometabolites enter the blood 
in excess amounts, they are neutralized in the liver (for example, phenol is converted into cre‐
sol), form sulfates and conjugates with amino acids (glycine and glutamine) and glucuronic 
acid, etc., then in the form of water‐soluble compounds excreted in the urine.
MS‐based metabolomics studies (using LC‐ and GH‐MS) on germ‐free (gnotobiotic) mam‐
mals showed that many classes of low molecular weight compounds (free or conjugate) in 
blood are of microbial origin [4]. For example, many phenolic metabolites, such as phenyl sul‐
fate, p‐kresol sulfate, conjugate of phenyl propionic, and cinnamic acids (phenylpropionylg‐
licine and cinnamoylglicine) observed only in normal (conventional) animals. Concentrations 
of other phenolic compounds were many times higher in the blood of normal animals com‐
pared to germ‐free animals, p‐value 10−8 to 10−9, such as phenyl benzoic conjugate (hippuric) 
and phenyl acetic conjugate (phenylacetylglycine).
The humans carry out their activities in close contact with the inhabiting microflora from 
the first day after birth to the last, i.e., throughout life. In ontogenesis, there created a system 
of human‐microbiota, thanks to close and mutually beneficial metabolic integration [5]. The 
presence of integration of host‐microbial metabolism is confirmed by the fact that
• the number of microbial cells inhabiting the human community is huge, according to some 
authors exceeds [6] or at least comparable [7] with the number of cells in the human body;
• high speed reproduction of microorganisms and cell renewal of the microbial community 
indicates active metabolic process in bacteria;
• qualitative and quantitative composition of biological community indicates the existence 
of mechanisms of regulation within the microbial community, the so‐called “quorum 
sensing;”
• number of mechanisms of immunoreactivity aimed at maintaining a symbiotic relation‐
ship that indicates the existence of mutual regulation through a system of common me‐
tabolites and/or signaling molecules.
The results of our research allow us to assert that the number of products of microbial metabo‐
lism namely phenolic acids entering the bloodstream of critically ill patients in large amounts 
can block the respiratory chain of mitochondria, disrupting the functions of organs and tis‐
sues that are directly involved in the genesis of multiple organ failure (MOF).
These relationships change radically in patients with severe illnesses, reaching a maximum 
deviation from the norm in critical conditions, until the development of irreversible  disorders 
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of homeostasis and death of the host organisms. Massive tissue damage of any origin is 
accompanied by hypoxia, shortage of energetically plastic materials, which reflects violations 
of the metabolic processes of microorganism and influences the metabolism of its microbiota. 
When the host organism is under extreme conditions (massive hemorrhage, hypoxia, hypo‐ 
or hyperthermia, starvation, hypovolemia, poisoning, irradiation, etc.), that means the rapid 
changes in the environment of microorganisms inhabiting gut of host.
Sepsis is characterized by sudden depletion and simplification of the microbiota as follows:
• first of all, destroyed biofilms of microbial symbionts, namely indigenous anaerobes 
(Bifidobacteria, Lactobacilli, etc.) [8];
• facultative anaerobes (enterobacteria, staphylococci, etc.) form biofilms in the upper diges‐
tive tract (bacterial expansion in the small intestine) [9, 10];
• clinically it is manifested by the failure of intestinal barrier and bacterial translocation 
[11, 12];
• the blood circulating bacteria from gut “in search of” more favorable conditions, which are 
recorded as “bacteremia” [13];
• resistant to the ongoing antibiotic treatment, bacteria remains in the micro thrombus, exu‐
date, and damaged epithelium/endothelium, forming local foci of infection [14].
3. Why aromatic microbial metabolites (AMM) are the most important  
in sepsis?
To study the metabolomics profile of biological fluids different technologies including the most 
gas chromatography‐mass spectrometry (GC‐MS), liquid chromatography‐mass spectrometry 
(with two mass analyzers in one mass spec instrument)  (LC‐MS/MS), 1H (H)‐ (proton nuclear 
magnetic resonance) spectroscopy (NMR), etc. are used. Global metabolic profiling—spanning 
hundreds of small molecules—holds the potential to reveal not only host and microbial metab‐
olites, novel biomarkers, but also provides insight into disease pathogenesis.
In our experiments, we used GC‐MS analysis of blood serum, as in sepsis in the blood enters 
the microbial exometabolites from the intestine and from foci of infection. Blood microbial 
metabolites spread throughout the body to the cells of all organs (Figure 1). Comparing qual‐
itative and quantitative composition of low molecular metabolites in the blood of different 
groups of patients, we found that most of qualitative and quantitative significant differences 
between the healthy and the sick are observed among aromatic metabolites. In the blood of 
healthy and sick people, we have identified and measured tens of aromatic metabolites such as 
phenol, benzole, and their derivatives (p‐cresol, benzyl alcohol, benzoic acid, 2,4‐dihydroxy‐
benzoic acid, 3,4‐dihydroxybenzoic acid, and p‐hydroxybenzoic acid), carbolic acids (lactic, 
malic, fumaric, succinic, 2‐ketoglutaric, 2‐hydroxyglutaric, 2‐hydroxybutyric, etc.), phenyl 
carboxylic acids (phenylacetic, p‐hydroxyphenylacetic, 2‐hydroxyphenylacetic, phenyl‐
propionic, p‐hydroxyphenyl propionic, cinnamic, p‐hydroxyphenyl cinnamic, phenyllactic, 
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p‐ hydroxyphenyllactic, phenylpyruvic, p‐hydroxyphenylpyruvic, and o‐hydroxyphenylace‐
tic), indolic acids (1‐indoleacetic acid and 3‐indoleacetic acid), etc.
It proved the microbial origin of phenyl carboxylic acids in the human body [15]. The exami‐
nation and comparison of different groups of people discovered that some aromatic metabo‐
lites in the blood of patients with sepsis strongly differed from all other groups of patients. We 
named these compounds as “sepsis‐associated” aromatic microbial metabolites (AMM). On 
chemical structure, they can be attributed to phenolic or phenyl carboxylic acids (Figure 2).
Jenner et al. [16] analyzed the profile of aromatic compounds (about 50) in the gut of healthy 
people. The results showed that they are quantitatively dominated by such metabolites
  PhAA > p‐HPhAA > 3, 4 di‐HCinA > PhPA > BA (1)
Our research has shown that most of these AMMs are also present in the serum of healthy 
people [17], but in a different ratio:
  p‐HPhLA > BA > p‐HPhAA > PhAA > PhLA > PhPA (2)
Differences in the proportion of AMM in the blood compared to the intestine can be explained 
by the fact that most hydrophilic (p‐HPhAA, p‐HPhLA, and PhLA) metabolites are excreted 
by the kidneys, while lipophilic metabolites (BA, PhAA, and PhPA) are absorbed by cells of 
tissue barriers (intestinal wall, lymphoid tissue, liver, vascular endothelium, etc.).
Figure 1. Sources and targets of serum aromatic microbial metabolites (AMM) in sepsis.
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It is important to note that all patients with a diagnosis of sepsis discovered the highest levels 
in the serum of PhLA, p‐HPhLA, p‐HPhAA, and always‐no PhPA [18].
The comparisons of the levels of microbial aromatic metabolites (AMM) in the blood of septic 
patients versus a normal level of metabolites in the blood and in bowel (fecal water) of healthy 
are presented in Table 1.
Figure 3 presents visual comparison data on serum concentrations of six AMM (GC‐MS, 
ng/ml) in groups of healthy and patients with chronic heart failure, familial mediterranean 
fever (FMF), pneumonia, and sepsis. It is important to note that the concentration of lipophilic 
AMM is so small that the image is almost not visible. At the same time, the concentration of 
the three “sepsis‐associated acids” (PhLA, p‐HPhLA, and p‐HPhAA) in patients with sepsis 
greatly exceeds the levels of AMM when comparing groups.
The studies had different questions as follows:
1. Does not such a high level of AMM in violation of their elimination from the body, for 
example, in renal or hepatic failure (excluding sepsis)?
2. Increase of sepsis‐associated AMM in patients with severe trauma without sepsis?
3. What about patients with phenylketonuria?
After the examination of six different groups of patients, such doubts were dispelled and 
again shows that sepsis is characterized by increase of all three “sepsis‐associated” AMM—
PhLA, p‐HPhLA, and p‐HPhAA (Figure 4).
Figure 2. “Sepsis‐associated” aromatic microbial metabolites (AMM).
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The first report on the potential diagnostic value of the level of AMM in sepsis has been 
reported to us on the International Sepsis Forum (ISF‐2007, Paris) and then was published 
[19]. There was a presentation on the results of GC‐MS analysis, which revealed the highest 
Figure 3. High serum concentrations of p‐HPhAA, p‐HPhLA, and PhLA (GC/MS, ng/ml) in septic patients versus 
healthy and chronic heart failure, familial mediterranean fever (FMF), and pneumonia.
AMM AMM in the blood of septic 
patients, μM, median  
(IR 25–75%)
AMM in the blood of 
healthy, μM, median  
(IR 25–75%)
AMM in the bowel (faecal 
water) of healthy, data from 
[7], μM
Lipophilic AMM
PhPA nd* 0,2 (0,1–0,4) 200‐600
PhAA 0,4 (0,1–0,7) 0,4 (0,3–0,6) 400‐1100
BA 0,9 (0,8–2,0) 0,7 (0,6–0,8) 23‐25
Hydrophilic AMM
di‐HCinA nd nd 50‐200
PhLA 2,7 (1,4–5,1) 0,3 (0,2–0,4) nd
p‐HPhLA 7,6 (2,9–15,5) 1,1 (0,9–2,0) nd
p‐HPhAA 14,1 (7,8–35,9) 0,5 (0,4–0,6) 60‐400
* nd, not detected.
Table 1. The levels of microbial aromatic metabolites (AMM) in the blood of septic patients versus a normal level of 
metabolites in the blood and in bowel (faecal water) of healthy.
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levels of p‐HPhAA, p‐HPhLA, and PhLA in 44 septic patients. Then, the levels of AMM in 
patients were examined in the dynamics. It is shown that aromatic metabolites accurately 
reflect the efficiency of ICU treatment and the prognostic significance of the some aromatic 
metabolites is higher than that of lactate [20].
The highest levels of “sepsis‐associated” AMM discovered in patients with a fatal outcome 
in end‐stage sepsis, on the last day of life (<24 h before death). Table 2 shows a significant 
Figure 4. The levels of six phenyl carboxylic acids in blood of six groups of patients (GC‐MS, μM).
Parameter Time to death (retrospective analysis) The multiplicity of 
changes, Me
p=
48‐25 h 24‐0 h
MODS_2 5 (3—7) 9 (6—10) 1,8 <0.001
Lactate, μM 3,6 (2,4—5,1) 4,2 (3,0—10,6) 1,2 0.030
PhLA, μM, median  
(IR 25‐75%)
4,27 (2,14—9,33) 7,97 (5,07—17,90) 1,9 <0.001
p‐HPhAA, μM, median 
(IR 25‐75%)
10,45 (1,99—25,81) 20,14 (7,27—65,49) 1,9 <0.001
p‐HPhLA, μM, median 
(IR 25‐75%)
9,14 (5,73—25,51) 22,06 (13,64—67,04) 2,4 <0.001
∑3 AMM, μM, median 
(IR 25‐75%)
33,47 (12,40—63,98) 78,02 (38,92—156,26) 2,3 <0.001
Table 2. Some clinical and laboratory data of the monitoring terminal ICU patients in the last 2 days of life (n = 34).
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increase in the level of AMM (p‐HPhAA, p‐HPhLA, and PhLA) in the last 2 days of life in ter‐
minal ICU patients (n‐34) and significantly the highest concentration for the moment of death.
Later, the relationship was also found between p‐HPhLA and 28‐day mortality in a large 
study from Roger et al., after analysis of metabolic profiling of plasma samples from 90 ICU 
subjects [21].
These facts point to the possible own biological activity of AMM and their direct participation 
in the mechanisms of pathogenesis and thanatogenesis of sepsis.
4. The role of microbial metabolites in the pathogenesis of sepsis
4.1. Bacterial load and neutrophils
Studies have confirmed that increased bacterial load is accompanied by an increase in the 
total blood concentration of AMM [22] that contributes to the transition from local infection 
to sepsis. This can be observed with late diagnosis, inadequate antibiotic therapy, or delayed 
surgical rehabilitation of the infection focus. So, when comparing patients with different 
severity of bacterial infection, it is shown that in the group of patients with sepsis, serum con‐
centrations of hydrophilic AMM were significantly higher versus the group of local infections 
of skin and soft tissues [23].
It is shown that the AMM level reflects the severity of the infectious process and is directly 
correlated with the number of clinical signs of inflammation, indicators of severity APACHEII 
and SOFA scores [24].
Neutrophils are the first line of defense against bacteria. They quickly migrate to the site 
of infection or inflammation, neutralize foreign particles, phagocytose, and destroy bacteria. 
Polymorphonuclear leukocytes also transmit signals to other cells of the nonspecific immune 
system about the threat of invasion of foreign agents. Neutrophil dysfunction is one of the key 
mechanisms of severe infection and sepsis development.
Thus, the microbial load in sepsis associated with microbial metabolites. To test the hypoth‐
esis about the influence of AMM on the phagocytic activity of neutrophils, experiments were 
conducted in vitro. It was shown that in vitro some sepsis‐associated AMM in clinically rele‐
vant concentrations are able to inhibit phagocytic activity of neutrophils. In experiments with 
neutrophils observed the disruption caused by the influence of AMM in vitro. They were asso‐
ciated with suppressed production of ROS and similar to those found in patients with sepsis; 
therefore, among the reasons for mitochondrial dysfunction in sepsis can play an important 
role in the imbalance of microbial metabolites [25].
4.2. Organ dysfunction
Retrospective analysis of the causes of deaths by group of authors (Vincent, Nelson, and 
Williams), using a database of 28 countries, which contains all information about 4459 patients 
with severe sepsis [26]. It has been shown that for the period, by the 28th day from the time 
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of diagnosis of sepsis died 1201 patients and mortality was 27%. The analysis showed that all 
the deceased patients showed an increase in the dynamics of the severity of organ disorders, 
which were objectively evaluated by the growing points on the SOFA scale. The main causes 
of death were multiple organ failure (MOF) associated with sepsis (43%) and refractory septic 
shock (22.6%). At the same time, the results of histological findings in postmortem studies of 
organs and tissues from patients, who died from sepsis, are not consistent with the degree 
of the organ dysfunction. Cells of heart, kidney, liver, and lungs in the death of sepsis were 
subjected to minimal changes. In patients with clinical signs of myocardial depression had no 
data on the damage of cardiomyocytes. Kidney (nephrons and tubules) were intact. That is, 
the organs looked normal while they are clinically noted MOF with fatal outcome [27]. Thus, 
it is quite reasonable today in the center of attention—the causes and mechanisms of MOF in 
patients with sepsis [28].
Fortunately, more than half of patients with sepsis survive. Organ dysfunction in sepsis is 
sometimes called “hibernation‐like state” from the point of view of its reversibility [29]. In 
other words, MOF means something disrupts normal functioning of the cells, in sepsis it is 
not so much hypoxia, but how much a reduction in energy availability. Unique to sepsis are 
the coexisting findings: metabolic acidosis means increased oxygen demand, at the same time 
recorded a decrease of oxygen consumption. The greatest attention is paid to study mitochon‐
drial mechanisms of sepsis‐induced organ failure.
It is known that the mitochondria in human cells are similar to bacteria not only in size. 
Mitochondria have their own DNA, which is similar to bacterial DNA and very different 
from the DNA of human cells. Mitochondria and bacteria have also some similar pathways 
for energy production. A number of other biological characteristics also point to a prokaryotic 
origin of mitochondria in ontogenesis [30].
4.3. Mitochondrial dysfunction
According to the authors, mitochondria reduce the supply of energy to the cell to cause meta‐
bolic shutdown. This adaptive mechanism is similar to hibernation, it prevents massive cell 
death and thereby, gives a chance of complete recovery of organ function after recovery in 
survivors [31].
The concept of mitochondrial dysfunction and bioenergetics failure during sepsis is not new 
[32], but it remains unclear why in sepsis does this unique mechanism and what role bacteria 
play. Our experimental approaches have revealed the influence of AMM on mitochondrial 
function that have novel and interesting findings [33]. It turned out that some aromatic micro‐
bial metabolites are able to inhibit the NAD‐dependent mitochondrial respiration. It is shown 
that the degree of inhibition depends on the chemical structure of metabolites [34]. In the 
experiment, in vitro the degree of inhibition of respiration of mitochondria by cinnamic acid 
was taken as 100% (Figure 5). We can conclude that inhibition of mitochondrial respiration 
can only occupy lipophilic AMM and its derivates (benzoic and cinnamic acids are metabo‐
lites of PhPA).
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The inhibition of NAD-dependent respiration of mitochondria by cinnamic acid was taken 
to be 100%. The concentration of phenolic acids was 100 μM. Data are expressed as the 
means ± SEM of five independent determinations 
Figure 5. Effect of phenolic acids of microbial origin on NAD‐dependent respiration of mitochondria.
* cinnamic (CA), benzoic (BA), phenylpropionic (PPA), phenylace	c (PAA),
p-hydroxyphenylpropionic (p-HPPA), phenyllac	c (PLA), p-hydroxyphenyllac	c (p-HPLA
Data are expressed as means ± SEM of five independent determinaons
at a concentraon of 100 µM
Figure 6. Comparison of the effect of phenolic acids* on menadione‐activated ROS production by mitochondria.
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When studying the effect of AMM on the production of ROS by mitochondria, activated by 
menadione, the differences were in the opposite direction: lipophilic AMM (cinnamic CA, 
benzoic BA, phenylpropionic PPA, and phenylacetic PAA) activated, and hydrophilic AMM 
(p‐hydroxyphenyl propionic p‐HPPA), phenyllactic PLA, and p‐hydroxyphenyllactic p‐HPLA 
opposite suppressed (Figure 6). It is known that a very large number of mitochondrial reac‐
tive oxygen species (mROS) directly damage proteins, lipids, and nucleic acids. At the same 
time, a complete lack of ROS production is also very harmful, so the lower levels of mROS 
are necessary for normal cell homeostasis. Low levels mROS perform the functions signaling 
molecules and need to adapt to the stress [35].
It is also shown the in vitro ability of microbial metabolites to influence the amount of metabo‐
lites of the tricarboxylic acid cycle in the blood of septic patients affects the activity of mito‐
chondrial enzymes [36]. The clinical confirmation and significance of these facts to be assessed 
in the near future.
4.4. Hemodynamic instability and shock
Some authors view excessive bacterial load as the main cause of uncontrollable progression 
of hypotension in critically ill patients [37]. It has been shown that the earlier the onset of 
antimicrobial therapy (immediately on admission of a critical patient with signs of arterial 
hypotension) may have a significant impact on survival. So, hemodynamic instability and 
septic shock are undoubtedly connected with bacteria, but how? Attempts to explain the 
leading effect only of LPS (structural component of cell walls of gram‐negative rods or endo‐
toxin) is not satisfied, because they do not allow you to monitor and manage this process.
Our clinical monitoring of patients with high risk of septic shock indicates the potential 
involvement of AMM in the development of this life‐threatening condition, accompanied by 
high mortality [38, 39]. In our view, an important role is played by disruption of the normal 
participation of microflora in the metabolism of aromatic amino acids, especially tyrosine 
and products of its metabolism. First, it is shown that an excess of toxic endogenous and 
microbial metabolic products of tyrosine and dopamine cannot be fully disposed of anaerobic 
microbiota [40]. However, these aromatic metabolites on the principle of feedback can inhibit 
the normal metabolic pathway of synthesis of hormones. Recently, we have obtained indirect 
evidence of “microbial” mechanism in the development of septic shock through the inhibition 
of tyrosine hydroxylase. In this way, the products of microbial metabolism may interfere with 
the normal synthesis of catecholamines from dopamine and to result in arterial hypotension. 
Search connection between endogenous hormones and bacterial exometabolites potentially 
related to hypotension in patients with infection will continue [41].
5. Conclusion
Sepsis integration of metabolism of humans and microbiota is disturbed and takes patho‐
logical character directed against the owner. Previously, it has been shown that phenyl car‐
boxylic acids could have microbial origin in human blood of healthy people. Microbiota 
has to survive under adverse conditions, the indigenous anaerobic microflora are not able 
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to fulfill its “helpful” metabolic functions [14]. Studies have shown that in septic patients, 
most violations occur in the metabolism of aromatic compounds. We documented imbal‐
ance of aromatic acids metabolites in septic patients: absence of serum PPA and high level 
of PLA, p‐HPLA, and p‐HPAA are associated with severity and mortality. Experimentally 
demonstrated the influence of some aromatic microbial metabolites (AMMs) on mitochon‐
drial function, participate in the development of organ dysfunctions in sepsis. In‐vitro some 
AMMs in clinically significant concentrations are able to inhibit phagocytic activity of neu‐
trophils. Metabolism of tyrosine is severely disrupted in sepsis. Some microbial exometabo‐
lites may suppress the activity of enzymes such as tyrosine‐hydroxylase. There is an excess 
of products of microbial biodegradation of endogenous metabolites of aromatic amino acids 
in the blood, including the reason of failure function of indigenous anaerobes. The obtained 
results indicate new promising target in the diagnosis, prevention, and treatment of sepsis.
We believe that the development of laboratory technologies, the use of other more sophisti‐
cated methods aimed at detection and measurement of metabolites of microbial origin in the 
human body, is the real path to success in solving the problem of sepsis in the near future.
6. Methods
We used gas chromatography‐mass spectrometry (GC‐MS) method to quantify metabolites 
in human serum from patients with pneumonia or abdomen sepsis, patients with local infec‐
tion of the skin and soft tissues, healthy (as control). In the process, we adapted the sample 
preparation and measurement method for working in clinical laboratory conditions on GC‐
FID [42]. Clinical and laboratory data, APACHE II and SOFA scores in patients were matched. 
Methods for in vitro studies of the biological activity of microbial metabolites on the neutro‐
phils and mitochondria are described in detail in articles listed in references. In microbio‐
logical experiments, we measured also the concentration of the metabolites by GH‐MS in the 
nutrient medium after the cultivation of various species of aerobic or anaerobic bacteria. Data 
were compared by Mann‐Whitney U‐test; p‐values less than 0.05 were considered significant.
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